Theratechnologies THTX

Annual report 2024
added 04-25-2026

Theratechnologies DIO Ratio 2011-2026 | THTX

Annual DIO Ratio Theratechnologies

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	373	672	1.15 K	1.58 K	1.05 K	-	92.2 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
92.2 K	373	16.2 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Nymox Pharmaceutical Corporation NYMX	5.46	-	-19.68 %	$ 18.4 M	Canada
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aptorum Group Limited APM	4.89	$ 0.9	-2.33 %	$ 6.62 M	China
	ACADIA Pharmaceuticals ACAD	295	$ 21.96	-0.68 %	$ 3.64 B	USA
	Amphastar Pharmaceuticals AMPH	166	$ 21.41	1.9 %	$ 1 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Aquestive Therapeutics AQST	120	$ 4.08	0.25 %	$ 436 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 23.26	1.75 %	$ 2.96 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.44	-5.88 %	$ 383 M	Britain
	BioXcel Therapeutics BTAI	1.56 K	$ 1.06	-3.64 %	$ 12.9 M	USA
	CASI Pharmaceuticals CASI	47.4	-	-	$ 35.4 M	USA
	bluebird bio BLUE	125	-	-	$ 546 M	USA